10:30-12:50

　　 　　

主持 Moderators	(), (), (), (), ()
讨论嘉宾 Discussants	(), ()
10:30-11:00	第一大类肺高血压：肺动脉高压 Group 1 PH: Pulmonary arterial hypertension	()
11:00-11:30	第二大类肺高血压：左心疾病相关肺高血压 Group 2 PH: Pulmonary hypertension associated with left heart disease	()
11:30-12:00	第三大类肺高血压：肺疾病或缺氧相关肺高血压 Group 3: PH: Pulmonary hypertension associated with lung disease and/or hypoxia	()
12:00-12:30	第四大类肺高血压：肺动脉阻塞相关肺高血压 Group 4 PH: Pulmonary hypertension associated with pulmonary artery obstructions	()
12:30-12:50	PAH靶向治疗进展	()

13:30-15:30

　　 　　

主持 Moderators	(), (), (), (), (), (), ()
讨论嘉宾 Discussants	(), (), ()
13:30-13:50	房间隔造口术治疗肺高血压 BAS in the treatment of pulmonary hypertension	()
13:50-14:10	肺高血压肺移植 Lung Transplantation in pulmonary hypertension	()
14:10-14:30	肺动脉去神经术治疗肺高血压 PADN in the treatment of pulmonary hypertension	()
14:30-14:50	肺动脉内膜剥脱术治疗 CTEPH PEA in the treatment of CTEPH	()
14:50-15:10	妊娠肺动脉高压的管理 Management of pulmonary hypertension during pregnancy	()
15:10-15:30	系统性红斑狼疮相关肺动脉高压风险预测 Predicting the Risk of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus	()

15:30-16:50

　　 　　

主持 Moderators	(), (), (), (), ()
讨论嘉宾 Discussants	(), (), ()
15:30-15:50	Changes in the Characteristics and Initial Treatments of Pulmonary Hypertension Between 2008 and 2020 in Japan	()
15:50-16:10	Pulmonary Hypertension Caused by Fibrosing Mediastinitis	()
16:10-16:30	Prevalence, Genetic Background, and Clinical Phenotype of Congenital Thrombophilia in CTEPH	()
16:30-16:50	Time-Velocity Integral of Left Ventricular Outflow Tract Predicts Worse Long-Term Survival in Pulmonary Arterial Hypertension	()